DeepMed Research

National Institute of Mental Health, Dhaka

🇧🇩Bangladesh

Country: 🇧🇩Bangladesh

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Phase 1

Recruiting

Conditions: Long COVID
Post Acute Sequelae of COVID-19

Interventions: Drug: 11C-PS13

First Posted Date: 2025-04-10

Last Posted Date: 2025-05-21

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 60

Registration Number: NCT06920628

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Phase 1

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Drug: 18F-PF-06445974

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-26

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 30

Registration Number: NCT06795581

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: 11C-JMJ-129

First Posted Date: 2025-03-13

Last Posted Date: 2025-04-16

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 40

Registration Number: NCT06874205

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety

Phase 2

Recruiting

Conditions: Psychiatric Disorders
Anxiety Disorders

Interventions: Behavioral: Gaze-Contingent Music Reward Therapy

First Posted Date: 2024-09-19

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 150

Registration Number: NCT06595953

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Phase 2

Recruiting

Conditions: Suicide
Depressive Disorder, Treatment-Resistant
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Excitatory Amino Acid Agents
Ketamine
Physiological Effects of Drugs
Depressive Disorder, Major
Mental Disorders
Mood Disorders

Interventions: Drug: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)
Drug: Placebo

First Posted Date: 2024-07-22

Last Posted Date: 2025-04-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 50

Registration Number: NCT06511908

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers

Early Phase 1

Recruiting

Conditions: Irritability

Interventions: Other: Frustration task

First Posted Date: 2024-07-03

Last Posted Date: 2025-04-18

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 40

Registration Number: NCT06484088

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Natural History of Depression, Bipolar Disorder and Suicide Risk

Recruiting

Conditions: Excitatory Amino Acid Agents
Molecular Mechanisms of Pharmacological Action
Anesthetics, Dissociative
Behavioral Symptoms
Suicide
Self-Injurious Behavior
Anesthetics
Depression, Unipolar
Depressive Symptoms
Depression, Bipolar

First Posted Date: 2024-06-17

Last Posted Date: 2025-05-13

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 500

Registration Number: NCT06462196

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia

Phase 4

Completed

Conditions: Major Depressive Disorder With Insomnia

Interventions: Drug: Mirtazapine Tablets

First Posted Date: 2023-08-07

Last Posted Date: 2024-04-02

Lead Sponsor: National Institute of Mental Health, Dhaka

Target Recruit Count: 135

Registration Number: NCT05978219

Locations: 🇧🇩
National Institute of Mental Health, Dhaka, Bangladesh

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Phase 1

Recruiting

Conditions: Depression

Interventions: Radiation: Lung scan
Drug: Apremilast
Drug: 18F-PF-06445974

First Posted Date: 2023-01-30

Last Posted Date: 2025-03-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 108

Registration Number: NCT05703685

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Recruiting

Conditions: Major Depression
Bipolar Disorder
Migraine

First Posted Date: 2023-01-03

Last Posted Date: 2025-04-08

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 1260

Registration Number: NCT05669703

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy